Gene Polymorphisms Influencing Steroid Synthesis and Action
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00485186 |
Recruitment Status
:
Withdrawn
First Posted
: June 12, 2007
Last Update Posted
: September 5, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Disorders of Sex Development Congenital Adrenal Hyperplasia Congenital Adrenal Hypoplasia Adrenal Insufficiency Mineralocorticoid Deficiency Intersex |
Study Type : | Observational |
Actual Enrollment : | 0 participants |
Observational Model: | Family-Based |
Time Perspective: | Prospective |
Official Title: | Investigation of Gene Polymorphisms Influencing Steroid Synthesis and Action in Patients With Deficient Steroid Biosynthesis and Disorders of Sex Development |
Study Start Date : | June 2007 |
Actual Primary Completion Date : | June 2013 |
Actual Study Completion Date : | June 2013 |

Group/Cohort |
---|
1 |
2 |

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Senior |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Disorders of Sex Development
- Congenital Adrenal Hyperplasia
- Congenital Adrenal Hypoplasia
- Adrenal Insufficiency
- Mineralocorticoid Deficiency
- Salt-loss
Inclusion Criteria:
- Disorders of Sex Development
- Congenital Adrenal Hyperplasia
- Congenital Adrenal Hypoplasia
- Adrenal Insufficiency
- Mineralocorticoid Deficiency
- Salt-loss

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00485186
Study Chair: | Paul-Martin Holterhus, MD | University of Schleswig-Holstein | |
Principal Investigator: | Felix G Riepe, MD | University of Schleswig-Holstein |
Responsible Party: | Felix Riepe, Prof. Dr., University of Schleswig-Holstein |
ClinicalTrials.gov Identifier: | NCT00485186 History of Changes |
Other Study ID Numbers: |
D429/05 |
First Posted: | June 12, 2007 Key Record Dates |
Last Update Posted: | September 5, 2013 |
Last Verified: | September 2013 |
Additional relevant MeSH terms:
Addison Disease Hyperplasia Adrenal Insufficiency Adrenal Hyperplasia, Congenital Adrenogenital Syndrome Disorders of Sex Development Hypoaldosteronism Genetic Diseases, X-Linked Pathologic Processes Adrenal Gland Diseases |
Endocrine System Diseases Urogenital Abnormalities Congenital Abnormalities Genetic Diseases, Inborn Steroid Metabolism, Inborn Errors Metabolism, Inborn Errors Metabolic Diseases Gonadal Disorders Autoimmune Diseases Immune System Diseases |